Celldex Therapeutics Inc (CLDX) is traded on NASDAQ in USA. It is located in NEW JERSEY, U.S.A and employs 196 people. Celldex Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 405.24 M. Celldex Therapeutics Inc has 135.98 M outstanding shares of which 7.89 M shares are currently shorted by private and institutional investors with about 5.82 trading days to cover.
CELLDEX THERAPEUT currently holds about 140.53 M in cash with (100.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03.
Check Celldex Therapeutics Probability Of Bankruptcy